The Provincial Government (Pemprov) of Bali continues to use the AstraZeneca Vaccine in the COVID-19 vaccination program. This is because the AstraZeneca Vaccine used in Bali is not the CTMAV547 batch which has been temporarily stopped by the Ministry of Health.
“(Yes the AstraZeneca vaccine) is still (in use),” said the Head of the Bali Provincial Health Office Ketut Suarjaya, on Monday (17/5/2021).
Suarjaya explained that until now Bali has not received the AstraZeneca vaccine batch CTMAV547 which has been temporarily suspended by the Food and Drug Supervisory Agency (BPOM). The AstraZeneca vaccines that arrive in Bali have batch numbers CTMAV514, CTMAV516, CTMAV539, and CTMAV544.
“This means that all AstraZeneca vaccines for Bali are not among those which have been withdrawn,” explained Suarjaya.
Previously, Bali had received 200 thousand doses of the AstraZeneca vaccine. This vaccine is used for three areas that are designed to be the green zone for COVID-19, such as the International Tourism Development Center (ITDC) in Badung Regency, Ubud in Gianyar Regency, and Sanur in Denpasar City.
After that, in early May Bali received 501 thousand doses of AstraZeneca vaccine again. This vaccine has been distributed to nine districts/cities in Bali.
Suarjaya said that the use of the AstraZeneca Vaccine in Bali also caused post-immunization follow-up events (AEFI) but in a mild form.
“It is certain that there are no serious symptoms. The vaccination activity for COVID-19 using AstraZeneca will certainly continue,” he explained.
According to Suarjaya, the post-immunization follow-up events (AEFI) experienced by the community after being vaccinated by AstraZeneca in Bali were in the form of fever and headaches. These mild symptoms have been resolved with febrifuge and did not reach the hospital.
“We have some mild AEFIs. In the form of fever and headaches, but they have been resolved with the provision of fever-reducing drugs or paracetamol. That’s all there is nothing like what happened in North Sulawesi,” he said.
However, Suarjaya admitted that he did not memorize the exact data of the people who experienced mild AEFI because it was not recorded. He only received information by telephone from several people.
“I did not memorize it because I was in several places and because the symptoms were mild so it was not recorded. Nobody was hospitalized. There were only the reports that after using Paracetamol fevers disappeared. And the reports were verbal only by telephone, “he said.
Previously it was reported, the Government has temporarily stopped the distribution and use of the AstraZeneca vaccine batch CTMAV547. Apart from these batches, the government ensures that the AstraZeneca vaccine is safe and asks the public not to hesitate.
Based on a written statement on the Ministry of Health’s website, Sunday (16/5), this termination was carried out for toxicity and sterility testing by Food and Drug Supervisory Agency (BPOM) as a form of government precaution to ensure vaccine safety.
Not all batches of AstraZeneca vaccines have been discontinued for distribution and use. Only batch CTMAV547 has been temporarily suspended pending the results of investigations and testing from BPOM which may take one to two weeks.
“This is a form of government caution to ensure the safety of this vaccine. The Ministry of Health urges the public to be calm and not be consumed by hoaxes circulating. The public is expected to always access information from reliable sources,” said Ministry of Health spokeswoman Dr. Siti Nadia Tarmizi.